Haimov Haim, Yosupov Natali, Pinchasov Ginnady, Juodzbalys Gintaras
Department of Oral and Maxillofacial Surgery, Lithuanian University of Health Sciences, KaunasLithuania.
J Oral Maxillofac Res. 2017 Jun 30;8(2):e1. doi: 10.5037/jomr.2017.8201. eCollection 2017 Apr-Jun.
The purpose of the study is to systematically review the osseointegration process improvement by bone morphogenetic protein coating on titanium implant surface.
An electronic literature search was conducted through the MEDLINE (PubMed) and EMBASE databases. The search was restricted for articles published during the last 10 years from October 2006 to September 2016 and articles were limited to English language.
A total of 41 articles were reviewed, and 8 of the most relevant articles that are suitable to the criteria were selected. Articles were analysed regarding concentration of bone morphogenetic protein (BMP), delivery systems, adverse reactions and the influence of the BMP on the bone and peri-implant surface . Finally, the present data included 340 implants and 236 models.
It's clearly shown from most of the examined studies that bone morphogenetic protein increases bone regeneration. Further studies should be done in order to induce and sustain bone formation activity. Osteogenic agent should be gradually liberated and not rapidly released with priority to three-dimension reservoir (incorporated) titanium implant surface in order to avoid following severe side effects: inflammation, bleeding, haematoma, oedema, erythema, and graft failure.
本研究旨在系统评价钛种植体表面骨形态发生蛋白涂层对骨结合过程的改善作用。
通过MEDLINE(PubMed)和EMBASE数据库进行电子文献检索。检索范围限定为2006年10月至2016年9月近10年发表的文章,且文章限于英文。
共检索到41篇文章,从中筛选出8篇最符合标准的相关文章。对这些文章分析了骨形态发生蛋白(BMP)的浓度、递送系统、不良反应以及BMP对骨和种植体周围表面的影响。最终,现有数据包括340个种植体和236个模型。
大多数研究表明,骨形态发生蛋白可促进骨再生。为诱导和维持骨形成活性,应进一步开展研究。成骨剂应逐渐释放而非快速释放,优先考虑三维储库(整合)钛种植体表面,以避免出现以下严重副作用:炎症、出血、血肿、水肿、红斑和移植失败。